From what I've seen, the side effects are reported to be way less, and if I needed something like this pharmaceutical and my doctor told me a new drug with lower side effects is coming soon and approx same price too, pending approval I'd be willing to try it.
Of course we're all wishing for blue skies with the SP, but as stated by MGMT multiple times that insurers are willing to pay in the ballpark of Q, so we need to take them on their word. If you don't believe them, then perhaps BOT isn't a good investment for you.
I don't have first hand knowledge of the health and insurance market in the US, and I'm not against having a counter view, I just ask pls provide some information why you believe why you're typing.
In saying that I'm confident in the outcomes and possibilities with BOT, and I guess at some time in the future I hope to say I made a great decision and was consequently rewarded in part with a high SP
BOT - Anything but charting, page-8343
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.010(2.41%) |
Mkt cap ! $734.6M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.5¢ | 39.5¢ | $3.680M | 8.989M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 297011 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 12027 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |